Automata, an automation company helping life sciences innovate, diagnose and discover at scale, today announced a $50 million (£36.8M) raise in Series B funding.
The round was led by Octopus Ventures with participation from returning investors Hummingbird, Latitude Ventures, ABB Technology Ventures, Isomer Capital as well as strategic investors including In-Q-Tel.
WHAT IT DOES
The firm’s Automata...
The reimbursement channel for digital health apps in Europe has traditionally been long and complex.
But new analysis from Research2Guidance (R2G) predicts reimbursement opportunities will improve significantly over the next few years.
An R2G report has categorised European countries into groups of leaders, fast followers, certifiers and laggards, based on their public health insurance system’s...
Fertility startup ExSeed Health closes £2.5M seed round
Male fertility startup ExSeed Health has announced the closure of a £2.5 million seed extension round, led by Ascension with participation from Trifork, Hambro Perks, and R42 Group.
The investment will drive further European expansion for the firm, which has teams in London and Copenhagen.
ExSeed’s smartphone-based sperm testing kit does...
Qure.ai scores £3.2M for AI-aided cancer detection
Artificial intelligence (AI) provider Qure.ai has secured £3.2 million from SBRI Healthcare, in partnership with the NHS cancer programme and NHS Accelerated Access Collaborative.
The funding will be used to demonstrate real-world evidence of AI-aided lung cancer diagnosis, using the firm’s qXR chest X-ray interpretation technology.
Prof David...
UK-based men’s health platform Numan has raised $20 million (£14.7M) in growth debt from Kreos Capital.
The financing completes a $60.1 million (£44.3M) Series B round, led by White Star Capital, with participation from Novator, VNV Global, and Anthemis Exponential.
WHAT IT DOES
Numan offers a digital subscription service for men’s health issues, including hair loss, gut and lung health, sexual...
Nostos Genomics raises €5M to speed up genetic disease diagnosis
Artificial intelligence (AI)-driven genetic analysis startup Nostos Genomics has closed a €5 million seed round with 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First.
The firm’s disease identification platform, AION, can identify gene variants responsible for more than 10,000 diseases, cutting diagnosis time from...
Thirona obtains EU MDR approval for AI eye screening software
Dutch medtech firm Thirona has been granted Class II CE certification under the EU Medical Devices Regulation (MDR) for its eye disease screening software.
The solution RetCAD uses artificial intelligence (AI) to analyse colour fundus images, showing the interior surface of the eye, for the presence of age-related macular degeneration...
Israeli investment firm eHealth Ventures (eHV) has announced the establishment of a $30 million venture capital fund for med tech and digital health companies, with the aim of raising $40 million.
The fund, called ‘eHV Advanced’, will focus on Israeli early-stage companies at seed stage, with a focus on diagnostics, digital monitoring, digital treatments, home care and bio-convergence. It will...
Huma acquires iPLATO healthcare
London-based patient engagement firm iPLATO Healthcare has been acquired by global healthtech firm Huma.
iPLATO’s software covers a network of 26.6 million patients across nearly 3,000 NHS primary care organisations and its myGP app is used by almost 2.4 million people in England.
The two companies will continue to operate independently but will combine their...
Virtual surgery platform Proximie partners with Vodafone Business
London-based healthtech platform Proximie, has announced a partnership with Vodafone Business to increase access to surgical healthcare and training.
Proximie’s technology allows healthcare to virtually ’scrub-in’, record, and interact with any connected operating room in the world.
The collaboration will bring Proximie’s connected...
